SFA
RXRX icon

Sequoia Financial Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Sequoia Financial Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Sell
11,203
-3,959
-26% -$13.2K ﹤0.01% 2133
2026
Q1 		$46.5K Buy
15,162
+5,156
+52% +$19.9K ﹤0.01% 1893
2025
Q4 		$40.9K Buy
+10,006
New +$49.6K ﹤0.01% 1903
2025
Q3 		– Sell
-12,399
Closed -$62.7K – 1800
2025
Q2 		$62.7K Sell
12,399
-206
-2% -$1.01K ﹤0.01% 1551
2025
Q1 		$66.7K Buy
+12,605
New +$91.9K ﹤0.01% 1340

Other funds holding RXRX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
KG
Kieckhefer Group Mequon, Wisconsin $246M AUM 51.29% 1-Year Est. Return
TMC
Themes Management Co Greenwich, Connecticut $151M AUM
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AWM
Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return
NWMG
National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

Sequoia Financial Advisors's RXRX Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Recursion Pharmaceuticals (RXRX) stake by 26% in Q2 2026, selling an estimated $13.2K and leaving 11,203 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Sequoia Financial Advisors first reported a position in RXRX in Q1 2025 and has held it in 5 quarters since. The position peaked at $66.7K in Q1 2025. 33 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Sequoia Financial Advisors held 11,203 shares of Recursion Pharmaceuticals worth $41.1K as of Q2 2026.
  • Sequoia Financial Advisors sold 3,959 Recursion Pharmaceuticals shares in Q2 2026, an estimated $13.2K.
  • Recursion Pharmaceuticals made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2133 holding.
  • Sequoia Financial Advisors first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Sequoia Financial Advisors's Recursion Pharmaceuticals position peaked at $66.7K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.